Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 59.61M | 32.33M | 24.4M | 20.65M | 16.05M | 11.76M | 7.63M | 5.44M | 3.35M | 1.94M | 929K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 59.61M | 32.33M | 24.4M | 17.53M | 10.84M | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -208.45M | -228.66M | -226.54M | -221.97M | -221.71M | -223.12M | -216.89M | -208.41M | -192.02M | -165.69M | -150.52M | -130.16M | -104.93M | -87.07M | -72.13M | -57.6M | -47.32M |
Interest Income | 19.77M | 22.45M | 22.45M | 21.41M | 19.41M | 16.82M | 16.82M | 12.96M | 7.83M | 2.37M | 2.37M | 443K | 140K | 78K | 78K | 62K | 107K |
Pretax Income | -180.68M | -198.36M | -196.72M | -192.38M | -196.45M | -199.79M | -192.5M | -192M | -179.14M | -157.33M | -147.64M | -125.2M | -137.22M | -120.31M | -112.51M | -98.75M | -53.36M |
Net Income | -181.01M | -198.71M | -197.03M | -192.65M | -196.83M | -193.78M | -186.52M | -187.28M | -173M | -155.71M | -145.96M | -122.19M | -135.46M | -120.31M | -112.51M | -98.75M | -53.36M |
Selling & General & Admin | 57.64M | 56.65M | 54.83M | 52.68M | 51.55M | 49.94M | 49.09M | 47M | 42.65M | 37.53M | 32.7M | 29.11M | 23.58M | 18.86M | 14.29M | 9.63M | 7.13M |
Research & Development | 210.43M | 204.35M | 196.11M | 189.94M | 186.21M | 184.95M | 175.42M | 166.85M | 152.72M | 130.1M | 118.75M | 101.05M | 81.35M | 68.2M | 57.84M | 47.96M | 40.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55K | -55K |
Operating Expenses | 268.06M | 260.99M | 250.94M | 242.61M | 237.76M | 234.88M | 224.51M | 213.85M | 195.37M | 167.63M | 151.45M | 130.16M | 104.93M | 87.07M | 72.13M | 57.6M | 47.32M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 268.06M | 260.99M | 250.94M | 242.61M | 237.76M | 234.88M | 224.51M | 213.85M | 195.37M | 167.63M | 151.45M | 130.16M | 104.93M | 87.07M | 72.13M | 57.6M | 47.32M |
Income Tax Expense | 322K | 349K | 308K | 271K | 381K | -6.01M | -5.99M | -4.72M | -6.15M | -1.62M | -1.68M | -3M | -1.76M | n/a | n/a | 18K | 18K |
Shares Outstanding (Basic) | 88.8M | 86.87M | 84.63M | 84.23M | 83.13M | 69.67M | 63.21M | 61.95M | 61.79M | 61.46M | 57.21M | 48.67M | 48.57M | 48.03M | 47.99M | 47.95M | 43.82M |
Shares Outstanding (Diluted) | 88.8M | 86.87M | 84.63M | 84.23M | 83.13M | 69.67M | 63.21M | 61.95M | 61.79M | 61.46M | 57.21M | 48.67M | 48.57M | 48.03M | 47.99M | 47.95M | 43.82M |
EPS (Basic) | -2.11 | -2.35 | -2.46 | -2.59 | -2.87 | -3.02 | -3 | -3.09 | -3.04 | -2.88 | -2.86 | -2.52 | -2.8 | -2.52 | -2.68 | -2.52 | -1.68 |
EPS (Diluted) | -2.11 | -2.35 | -2.46 | -2.59 | -2.87 | -3.02 | -3 | -3.09 | -3.04 | -2.88 | -2.86 | -2.52 | -2.8 | -2.52 | -2.68 | -2.52 | -1.68 |
EBITDA | -201.62M | -221.91M | -219.97M | -215.68M | -215.75M | -217.67M | -212.02M | -204.31M | -188.6M | -162.88M | -148.17M | -128.11M | -103.18M | -85.53M | -70.81M | -56.07M | -45.86M |
EBIT | -208.45M | -228.66M | -226.54M | -221.97M | -221.71M | -223.12M | -216.89M | -208.41M | -192.02M | -165.69M | -150.52M | -130.16M | -104.93M | -87.07M | -72.13M | -57.6M | -47.32M |
Depreciation & Amortization | 6.84M | 6.75M | 6.57M | 8.02M | 9.37M | 10.5M | 11.54M | 10.34M | 8.46M | 6.71M | 5.13M | 4.89M | 4.1M | 3.38M | 2.66M | 1.53M | 1.46M |